Literature DB >> 25669439

Investigation of subclinical atherosclerosis in psoriatic arthritis patients with minimal disease activity.

Baris Yilmazer1, Tayfun Sahin, Berrin Öztaş Unlu, Hale Maral Kir, Ayse Cefle.   

Abstract

The aim of this study was to investigate the presence of subclinical atherosclerosis among psoriatic arthritis (PsA) patients without any cardiovascular disease (CVD) or traditional cardiovascular risk factors through measurement of endothelial function and carotid intima-media thickness (IMT) and correlated with disease-related risk factors. Twenty patients with PsA according to classification criteria for psoriatic arthritis and 20 age- and sex-matched controls were included. Patients with risk factors for cardiovascular disease were excluded. Carotid IMT was measured using two-dimensional carotid ultrasonography (USG). Endothelial function was determined by measuring flow-mediated endothelial-dependent vasodilatation (FMD %) and nitrate-induced dilatation (NID %) using brachial artery USG. Additionally, serum asymmetric dimethylarginine (ADMA) level was obtained using ELISA methodology. In this cross-sectional study, FMD % was significantly more decreased among PsA patients versus control group [mean 11 % (median (range) %10.5 (8-15 %)] and mean 13.2 % [median (range) 12, 8 % (8.1-17.6 %), respectively; p = 0.01]. There was no significant difference in NID %, ADMA level and mean IMT or maximum IMT results. FMD % did not show a significant correlation with clinical and laboratory data of PsA patients. This study showed that endothelial dysfunction may be present in PsA patients with no CVD and traditional cardiovascular risk factors. The study findings lend support to the previous reports that suggested a potential relationship between PsA and atherosclerotic disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25669439     DOI: 10.1007/s00296-015-3228-y

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  44 in total

1.  Coronary flow reserve and asymmetric dimethylarginine levels: new measurements for identifying subclinical atherosclerosis in patients with psoriatic arthritis.

Authors:  Fabiola Atzeni; Piercarlo Sarzi-Puttini; Simona Sitia; Livio Tomasoni; Luigi Gianturco; Michele Battellino; Laura Boccassini; Vito De Gennaro Colonna; Antonio Marchesoni; Maurizio Turiel
Journal:  J Rheumatol       Date:  2011-06-01       Impact factor: 4.666

Review 2.  Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension.

Authors:  John Deanfield; Ann Donald; Claudio Ferri; Cristina Giannattasio; Julian Halcox; Sean Halligan; Amir Lerman; Giuseppe Mancia; James J Oliver; Achille C Pessina; Damiano Rizzoni; Gian Paolo Rossi; Antonio Salvetti; Ernesto L Schiffrin; Stefano Taddei; David J Webb
Journal:  J Hypertens       Date:  2005-01       Impact factor: 4.844

3.  The burden of carotid artery plaques is higher in patients with psoriatic arthritis compared with those with psoriasis alone.

Authors:  Lihi Eder; Jai Jayakar; Sutha Shanmugarajah; Arane Thavaneswaran; Daniel Pereira; Vinod Chandran; Cheryl F Rosen; Dafna D Gladman
Journal:  Ann Rheum Dis       Date:  2012-06-26       Impact factor: 19.103

4.  Prevalence and risk factors of atherosclerosis in patients with psoriatic arthritis.

Authors:  Oded Kimhi; Dan Caspi; Natan M Bornstein; Nitsan Maharshak; Alexander Gur; Yaron Arbel; Doron Comaneshter; Daphna Paran; Irena Wigler; David Levartovsky; Shlomo Berliner; Ori Elkayam
Journal:  Semin Arthritis Rheum       Date:  2006-10-25       Impact factor: 5.532

5.  Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis.

Authors:  D M van der Heijde; M A van't Hof; P L van Riel; M A van Leeuwen; M H van Rijswijk; L B van de Putte
Journal:  Ann Rheum Dis       Date:  1992-02       Impact factor: 19.103

6.  Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-α blockers and traditional disease-modifying antirheumatic drugs.

Authors:  Matteo Nicola Dario Di Minno; Salvatore Iervolino; Rosario Peluso; Raffaele Scarpa; Giovanni Di Minno
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-06       Impact factor: 8.311

7.  Noninvasive quantification of atherosclerotic lesions. Reproducibility of ultrasonographic measurement of arterial wall thickness and plaque size.

Authors:  J Persson; L Stavenow; J Wikstrand; B Israelsson; J Formgren; G Berglund
Journal:  Arterioscler Thromb       Date:  1992-02

8.  Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

Authors:  D D Gladman; V T Farewell; K Wong; J Husted
Journal:  Arthritis Rheum       Date:  1998-06

9.  Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis.

Authors:  D S Celermajer; K E Sorensen; V M Gooch; D J Spiegelhalter; O I Miller; I D Sullivan; J K Lloyd; J E Deanfield
Journal:  Lancet       Date:  1992-11-07       Impact factor: 79.321

10.  Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis.

Authors:  Manuela Di Franco; Francesca Romana Spinelli; Alessio Metere; Maria Chiara Gerardi; Virginia Conti; Francesca Boccalini; Cristina Iannuccelli; Francesco Ciciarello; Luciano Agati; Guido Valesini
Journal:  Mediators Inflamm       Date:  2012-08-07       Impact factor: 4.711

View more
  5 in total

1.  High prevalence of subclinical atherosclerosis in psoriatic arthritis patients: a study based on carotid ultrasound.

Authors:  Rosario Ibáñez-Bosch; Juliana Restrepo-Velez; Miguel Medina-Malone; Laura Garrido-Courel; Inmaculada Paniagua-Zudaire; Eduardo Loza-Cortina
Journal:  Rheumatol Int       Date:  2016-11-24       Impact factor: 2.631

Review 2.  Atherosclerosis in psoriatic disease: latest evidence and clinical implications.

Authors:  Lihi Eder; Dafna D Gladman
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

3.  Immune-Mediated Inflammation Promotes Subclinical Atherosclerosis in Recent-Onset Psoriatic Arthritis Patients without Conventional Cardiovascular Risk Factors.

Authors:  Rodolfo A Kolliker Frers; Vanesa Cosentino; Julia Tau; Eduardo M Kerzberg; Adriana Urdapilleta; Monica Chiocconi; Nora Kogan; Matilde Otero-Losada; Francisco Capani
Journal:  Front Immunol       Date:  2018-02-26       Impact factor: 7.561

4.  Meta-Analysis of Asymmetric Dimethylarginine Concentrations in Rheumatic Diseases.

Authors:  Gian Luca Erre; Arduino Aleksander Mangoni; Floriana Castagna; Panagiotis Paliogiannis; Ciriaco Carru; Giuseppe Passiu; Angelo Zinellu
Journal:  Sci Rep       Date:  2019-04-01       Impact factor: 4.379

5.  RNA sequencing of blood in coronary artery disease: involvement of regulatory T cell imbalance.

Authors:  Timothy A McCaffrey; Ian Toma; Zhaoquing Yang; Richard Katz; Jonathan Reiner; Ramesh Mazhari; Palak Shah; Michael Tackett; Dan Jones; Tisha Jepson; Zachary Falk; Richard Wargodsky; Dmitry Shtakalo; Denis Antonets; Justin Ertle; Ju H Kim; Yinglei Lai; Zeynep Arslan; Emily Aledort; Maha Alfaraidy; Georges St Laurent
Journal:  BMC Med Genomics       Date:  2021-09-03       Impact factor: 3.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.